Cite
HARVARD Citation
Terpos, E. et al. (2022). Health‐related quality of life in patients with relapsed/refractory multiple myeloma treated with pomalidomide and dexamethasone ± subcutaneous daratumumab: Patient‐reported outcomes from the APOLLO trial. American journal of hematology. 97 (4), pp. 481-490. [Online].